CD7 and lung cancer: By utilizing human NK cells (CD3−CD56+CD7+) as effectors, anti-CD47 antibody did not induce increased ADCC of lung cancer cell line cells or primary patients tumor cells compared to IgG1 isotype control (Figure 3F).